MABB Abstract Competition

There will be a competition for the best abstract in each of the following submission categories: 

• Medical Technology Students
  

• Residents
  

• Medical Technologists & Nurses
  

The abstracts will be on exhibit at the MABB annual seminar this coming April.  Each abstract may be no more than 2,400 characters.  The winner in each of the submission categories will receive a Technical Manual from one of the competition sponsors.

Submissions are due April 1, 2009 at 4 pm EDT.  Abstracts should be sent by e-mail to Dorothy Bergeron. 

Student and Professional Poster Presentations for the 2008 Meeting

Students:

Mai Drew:  Intrauterine Transfusion

Andrea Graham:  Cord Blood Banking

Ching-Ju Lu:  West Nile Virus:  Transfusion Transmission

Arthur McGee:  An Overview of Suface Modified, Encapsulated Hemoglobin Substitutes, Perfluorocarbons, and

                      Microbivores

Emily Rene:  Transfusion Related Acute Lung Injury (TRALI)

Aaron Stella:  Enzyme Converted Type O Blood

Professional:

Linda Martin, MT(ASCP):  StatSpin Express 3 Primary Tube Centrifuge:  Evaluation for Use in Blood Bank Testing (Iris Sample Processing)

Abstract Preparation & Submission Guidelines

Scientific Abstracts must include:

• Background - a brief statement of the purpose or why the study was done.
  

• Study Design - a statement concerning the methods (what was done).
  

• Results - a summary of the results observed.
  

• Conclusions - a statement of the author's conclusions based on the stated results. 
  

Case Studies must include Background, Case Report and Conclusions. 

Administrative abstracts should contain three sections:  Background or Introduction, Project or Study, and Conclusion. 

It is important that abstracts include specific reference to numbers studied and statistical significance of findings. 

Originality of work, adequacy of data and clarity of exposition are determinants in the selection of abstracts. 

Consider the following when submitting an abstract:

The combined length of the abstract body, title and table may not exceed 2,400 characters (not including spaces).  A character includes all letters, numbers and punctuation. 

Titles should be indicative of the content of the abstract.  The title should be brief and must be entered in title case.

Author names should have no titles or degrees listed.  Author institution should be listed as concisely as possible (include city, state or country).  Do not list authors in the body of the abstract text.

Tables may be used, graphs and charts are not allowed.

All units of measure should be expressed in the metric system; temperatures in Celsius.  Generic names of drugs must be given, typed in lower case.  If the proprietary name is given also, the first letter must be capitalized.  Unless an abbreviation is widely known and accepted (WBC, HIV), the parent phrase must be written in full the first time it appears in the abstract.  For example, hematopoietic progenitor cell (HPC) or filtration leukapheresis (FL). Do not use abbreviations in the title.  Avoid starting sentences with Arabic numbers.

The accuracy of the submitted abstract is the responsibility of the authors.  Authors should prepare and proofread their abstracts carefully prior to submission. 

Authors are encouraged to print a hard copy of their abstract for their records.

Notification of receipt of an abstract will be sent electronically to the submitting author. 

Submission of an abstract implies a commitment by the author(s) to present the abstract at the upcoming MABB seminar.  Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter. 

Presentations must be free of commercial bias for or against any product.  If the abstract involves commercial products it must be objective and rely on scientific methods.  Generic names should be used whenever possible.  If trade names are used, they should not be that of a single company.  The intent is to avoid promotional abstracts for specific purposes.  Reports of scientific research must conform to generally accepted standards of experimental design, data collection and analysis.

Author will need to indicate within the abstract submission any commercial involvement, support , or conflicts.  The following are examples of how to note this information:  "Funded by XYZ Corporation" or "Dr. XYZ is a member/grant recipient etc. of ABC Corporation."

Reasons for Rejection of Abstract

• Conclusions are not supported by data.
  

• No conclusions;  restating results are not colclusions.  Conclusions should state impact of the work.
  

• Presentation of data is not clear or cannot be followed.
  

• Style is unacceptable (e.g., typographical errors or poor sentence construction).
  

• Poor translation, incorrect format, insufficient scientific impact or merit and lack of originality.